Differential Expression of Somatostatin and Dopamine Receptor Subtype Genes in Adrenocorticotropin (ACTH)-secreting Pituitary Tumors and Silent Corticotroph Adenomas-Reference-Cited by-同舟云学术

Differential Expression of Somatostatin and Dopamine Receptor Subtype Genes in Adrenocorticotropin (ACTH)-secreting Pituitary Tumors and Silent Corticotroph Adenomas

Published:2009 Issue:4 Volume:56 Page:579-584
ISSN:0918-8959
Container-title:Endocrine Journal
language:en
Short-container-title:Endocr J

Author:

TATENO Toru¹,KATO Masako¹,TANI Yuji¹,OYAMA Kenichi²,YAMADA Shozo²,HIRATA Yukio¹

Affiliation:

1. Department of Clinical and Molecular Endocrinology, Tokyo Medical and Dental University Graduate School

2. Departments of Hypothalamic and Pituitary Surgery, Toranomon Hospital

Publisher

Japan Endocrine Society

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism

Link

http://www.jstage.jst.go.jp/article/endocrj/56/4/56_K08E-186/_pdf

Reference28 articles.

1. Cushing's Syndrome

2. 2. Tateno T, Izumiyama H, Doi M, Yoshimoto T, Shichiri M, Inoshita N, Oyama K, Yamada S, Hirata Y (2007) Differential gene expression in ACTH -secreting and non-functioning pituitary tumors. Eur J Endocrinol 157:717-724

3. 3. Lamberts SW, Oosterom R, Neufeld M, del Pozo E (1985) The somatostatin analog SMS 201-995 induces long-acting inhibition of growth hormone secretion without rebound hypersecretion in acromegalic patients. J Clin Endocrinol Metab 60:1161-1165

4. Long-Term Effects of Depot Long-Acting Somatostatin Analog Octreotide on Hormone Levels and Tumor Mass in Acromegaly

5. Primary Medical Therapy for Acromegaly: An Open, Prospective, Multicenter Study of the Effects of Subcutaneous and Intramuscular Slow-Release Octreotide on Growth Hormone, Insulin-Like Growth Factor-I, and Tumor Size

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Pituitary Adenoma: SSTR2 rs2236750, SSTR5 rs34037914, and AIP rs267606574 Genetic Variants, Serum Levels, and Ki-67 Labeling Index Associations;Medicina;2024-08-01

2. Update on Current Evidence for the Diagnosis and Management of Nonfunctioning Pituitary Neuroendocrine Tumors;Endocrinology and Metabolism;2023-12-31

3. Somatostatin and Somatostatin Receptors in Tumour Biology;International Journal of Molecular Sciences;2023-12-28

4. Pituitary Gland Therapies;Endocrinology;2023-12-15

5. Transcriptome-Derived Ligand-Receptor Interactome of Major PitNET Subgroups;Journal of Neurological Surgery Part B: Skull Base;2023-05-08